By optimizing glucose control, the technology aims to lower treatment costs and minimize complications related to poorly managed blood sugar and medication non-compliance,” stated Paul F. Hickey, ...

Genetic profiling, targeted therapies reshape oncology care in the region ... and efficiency to the table Shutterstock Cancer treatment is leaving behind its rigid, conventional approach and ...

Immunotherapy pioneer Mark Frohlich, MD, CEO of Indapta Therapeutics, discusses the promise of harnessing natural killer ...

TaiMed Biologics (4147 TWO), an innovation-driven biotech company, has Phase 2a clinical study evaluating TMB-365/TMB-380 ...

Germany has finally decided to start spending. Is this going to save its stagnating economy? The new fiscal package is the ...

The technology aims to optimize glycemic control, potentially reducing medication reliance and associated treatment costs. ReShape's system employs bio-electronic methods to regulate insulin ...

A new Northwestern Medicine study publishing in Nature Medicine suggests a promising alternative to previous attempts to ...

Hippocratic AI initially promoted a rate of $9 an hour for its AI assistants, compared with about $40 an hour for a ...

with the potential to treat Type 2 diabetes and hypoglycemia.” About The ReShape Diabetes Neuromodulation Device The ReShape Diabetes Neuromodulation system (formerly, Diabetes Bloc-Stim ...

ReShape Lifesciences® (Nasdaq: RSLS), the premier physician-led weight loss and metabolic health solutions company, today announced that the Company has received a ...

But after further examination, Hart determined that he was treating a dialysis patient, or someone with kidney failure. Such patients have to be carefully managed to avoid overloading their ...

But after further examination, Hart determined that he was treating a dialysis patient, or someone with kidney failure. Such patients have to be carefully managed to avoid overloading their ...